Expert Pitch
University of Washington

How families can use technology to juggle childcare and remote life during the COVID-19 pandemic

14-Apr-2020 4:45 PM EDT, by University of Washington

With thousands of schools and preschools closed and many states under "stay-at-home" orders to try to limit the spread of the novel coronavirus, families are facing a tough situation: trying to work — possibly remotely — while simultaneously being responsible for their children's education.

Julie Kientz, a University of Washington professor of human centered design and engineering is co-leading a new national study to help families discover technology that helps them both successfully navigate home-based learning and combat social isolation.

 "I think some parents had idealized scenarios where they said 'Oh, I'll just put my kid in front of a computer for a few hours and while I work, they'll do math and reading,'" Kientz said. "It all sounded great, but then after one day it's like, 'Oh gosh, this is not going to work.'"

One major issue, the researchers said, is that it's overwhelming trying to sort through seemingly endless technology options.

"People want to help parents manage this, and one easy way is to share resources. But in reality there are almost too many options," Kientz said. "As a parent, I was added instantly to about five or six different Facebook groups all about trying to navigate this situation. Everyone was posting a million different resources, such as brightly colored schedules for homeschool."

For their project, Kientz and team plan to recruit 30 diverse families with children ages 3 to 13 across the country. Participating families will be organized into three groups based on common family characteristics, such as children’s ages or work situations.

"We definitely want to include many different types of families, including parents who are still physically going to their jobs, parents who are in quarantine, intergenerational households and single parents," Kientz said. "But we want to make sure the study itself isn't creating more extra work for people who are already burdened."

Each family is expected to participate for about 30 minutes a week during the 10-week study. Families will reflect on how the technology they use helps or hinders their lives.

"What we're proposing to do here is find real stories from different types of families about what is helpful and what are the roadblocks," Kientz said. "Then we plan to immediately share that information back out using social media and regular Medium posts. We'll also provide a direct channel into some of the tools that support online learning, exercise and staying in touch at home."

In the later part of the study, families will design new or redesign existing technologies — such as a new educational skill for Amazon Echo. Then the families will test simple prototypes of these designs. Most of these activities will be completed as a family, though there may be some caretaker- or child-only activities as well.

"It's important to see things in terms of equity, too," Kientz said. "Some people don't have time to homeschool their kids, and a lot of these tools require high-speed internet access, iPads or other expensive equipment."

The study will look at how families in different situations are finding tools that they are able to access and use successfully. 

Details about the study and tips for families available here

Families that would like to participate can fill out the team's screener survey.

Kientz's other areas of expertise: Families, kids and technology; consumer health technologies; human-centered design; families using technology to navigate home-based learning during COVID-19

For more information, contact Kientz at

Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.

Showing results

110 of 2539